TCD unveils 15 new bioscience technologies

“A revised form of the drug aspirin which may allow it to be used as a long-term preventative treatment was one of 15 new bioscience technologies unveiled by Trinity College Dublin last night. The drug, with a working title of Safeprin, was developed by researchers in the university’s School of Pharmacy. While aspirin can be used to prevent heart attacks and strokes, prolonged use has been linked to gastric bleeding or ulcers which has restricted its use as a preventative treatment. TCD researchers say they have dealt with this limiting side-effect, opening the possibility of a new range of long-term uses for the drug …” (more)

[David Labanyi, Irish Times, 13 March]


Leave a Reply